Phase I/IIa Dose Finding Study of Triplet Regimen of Relatlimab Ipilimumab and NIvolumab in First Line Therapy of Metastatic Melanoma (TRINITY)
๐ The University of Texas M. D. Anderson Cancer Center โ Houston, Texas
View Study & Screener โExplore open interventional and observational research studies actively enrolling participants across the USA.
๐ Find Near Me with Distance Radius๐ The University of Texas M. D. Anderson Cancer Center โ Houston, Texas
View Study & Screener โ๐ Vanderbitl-Ingram Cancer Center โ Nashville, Tennessee
View Study & Screener โ๐ Mayo Clinic in Rochester โ Rochester, Minnesota
View Study & Screener โ๐ University of Florida โ Gainesville, Florida
View Study & Screener โ๐ UC San Diego Moores Cancer Center โ La Jolla, California
View Study & Screener โ๐ Washington University School of Medicine โ St Louis, Missouri
View Study & Screener โ๐ University of Virginia โ Charlottesville, Virginia
View Study & Screener โQualification depends on diagnostic staging, prior therapies, and health stability. Use our preliminary self-screener on individual study pages.
Under federal ACA ยง 2709, routine patient care costs are covered by health insurance. Review the study Informed Consent document with your doctor for details.